The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Smartleaf Asset Management LLC

Smartleaf Asset Management LLC increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 55.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,264 shares of the medical device company’s stock after buying an additional 451 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Cooper Companies were worth $116,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of COO. Victory Capital Management Inc. grew its stake in shares of Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Cooper Companies by 13.2% in the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares in the last quarter. Alecta Tjanstepension Omsesidigt acquired a new stake in shares of Cooper Companies in the fourth quarter valued at about $49,550,000. Swedbank AB grew its stake in shares of Cooper Companies by 14.0% in the fourth quarter. Swedbank AB now owns 1,629,602 shares of the medical device company’s stock valued at $149,809,000 after buying an additional 200,000 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 6.6 %

NASDAQ:COO opened at $85.00 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $92.52 and its two-hundred day moving average is $99.45. The Cooper Companies, Inc. has a 52 week low of $82.61 and a 52 week high of $112.38. The company has a market cap of $16.96 billion, a PE ratio of 43.59, a P/E/G ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. On average, analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

COO has been the subject of a number of recent research reports. Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Stifel Nicolaus reduced their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Finally, Piper Sandler reissued an “overweight” rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $111.89.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.